Showing results (791-800 of 809) with videos related to
Sort By:
Pageof 81
JAMA Oncology|June 2, 2022
Treatment With Adjuvant Abemaciclib Plus Endocrine Therapy in Patients With High-risk Early Breast Cancer Who Received Neoadjuvant Chemotherapy: A Prespecified Analysis of the monarchE Randomized Clinical TrialMiguel Martin, Roberto Hegg, Sung-Bae Kim, et al.Emerging Infectious Diseases|January 20, 2018
Borrelia miyamotoi Infections in Humans and Ticks, Northeastern ChinaBao-Gui Jiang, Na Jia, Jia-Fu Jiang, et al.Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|July 14, 2022
<i>Dermacentor silvarum</i>, a Medically Important Tick, May Not Be a Competent Vector to Transmit Jingmen Tick VirusLian-Feng Li, Ming-Zhu Zhang, Jin-Guo Zhu, et al.Nature Chemical Biology|May 15, 2025
Development of an allosteric adhesion GPCR nanobody with therapeutic potentialYuan Zheng, Dan Jiang, Yan Lu, et al.The Lancet. Oncology|December 9, 2022
Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trialStephen R D Johnston, Masakazu Toi, Joyce O'Shaughnessy, et al.Medrxiv : the Preprint Server for Health Sciences|November 19, 2025
Evidence for Aerosolized Environmental Bacterial Endotoxin as an Environmental Health HazardKeziyah Yisrael-Gayle, Edward Helderop, Chris Morin, et al.Microbiome|March 14, 2023
New insights into the impact of microbiome on horizontal and vertical transmission of a tick-borne pathogenLi-Feng Du, Ming-Zhu Zhang, Ting-Ting Yuan, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 15, 2018
Human Babesiosis Caused by a Babesia crassa-Like Pathogen: A Case SeriesNa Jia, Yuan-Chun Zheng, Jia-Fu Jiang, et al.Infection and Immunity|January 8, 2020
Cutaneous Immunoprofiles of Three Spotted Fever Group Rickettsia CasesNa Jia, Hong-Bo Liu, Yuan-Chun Zheng, et al.Journal of Hepatology|May 17, 2024
Targeting OXCT1-mediated ketone metabolism reprograms macrophages to promote antitumor immunity via CD8<sup>+</sup> T cells in hepatocellular carcinomaChu-Xu Zhu, Kai Yan, Liang Chen, et al.Pageof 81